Brucellar discitis is an infection of the intervertebral disc space by Brucella species, most commonly Brucella melitensis. It often arises in endemic regions through consumption of unpasteurized dairy or direct contact with infected animals. Unlike typical pyogenic discitis, brucellar involvement is insidious, presenting with low-grade fever, night sweats, and chronic back pain. Diagnosis relies on MRI (showing disc space narrowing, endplate erosion), positive serology (e.g., standard agglutination test ≥1:160), and culture or PCR confirmation.
Anatomy
Structure and Composition
The intervertebral disc (IVD) is a fibrocartilaginous structure that lies between adjacent vertebral bodies and forms a symphysis joint, permitting limited movement while providing load-bearing support. It consists of three main components:
-
Nucleus Pulposus (NP): A gel-like core composed of 66–86% water, type II collagen, and proteoglycans (primarily aggrecan), which retains water to disperse compressive forces evenly across the disc NCBIWikipedia.
-
Annulus Fibrosus (AF): A multilamellar ring of 15–25 concentric lamellae of fibrocartilage, with alternating collagen fiber orientation (~60° between lamellae) providing tensile strength and flexibility NCBIWikipedia.
-
Cartilaginous Endplates: Thin layers of hyaline cartilage anchoring the disc to the vertebral bodies and facilitating nutrient diffusion to and from the NP NCBIWikipedia.
Location, Origin, and Insertion
The IVD is situated between every pair of adjacent vertebrae from C2–3 through L5–S1 (23 discs total: 7 cervical, 12 thoracic, 5 lumbar) and accounts for about 25–33% of spinal height NCBIWikipedia. Embryologically, the NP derives from notochordal remnants, while the AF develops from surrounding mesenchyme; the endplates form from adjacent vertebral cartilage anlagen NCBIWikipedia. There is no disc between C1 and C2, where the atlas rotates around the axis NCBIWikipedia.
Blood Supply and Nerve Innervation
In healthy adults, the IVD is largely avascular: blood vessels persist only in the outer third of the AF and the cartilaginous endplates, then regress postnatally, leaving the NP dependent on diffusion Wheeless’ Textbook of OrthopaedicsNCBI. Nutrients (glucose, oxygen) diffuse through endplate pores from vertebral capillaries, while metabolites follow the reverse route Wheeless’ Textbook of OrthopaedicsNCBI. Innervation is also restricted to the outer AF via the sinuvertebral (recurrent meningeal) nerves, carrying nociceptive and sympathetic fibers that mediate discogenic pain KenhubKenhub.
Functions
Intervertebral discs perform at least six critical functions:
-
Shock Absorption: The NP’s high water content distributes compressive loads to prevent vertebral trauma WikipediaNCBI.
-
Load Bearing: Discs transmit axial forces between vertebrae, comprising ~25–33% of spinal column height NCBIWikipedia.
-
Flexibility and Mobility: The AF’s lamellar structure allows controlled flexion, extension, lateral bending, and axial rotation NCBIWikipedia.
-
Ligamentous Stability: Discs, together with anterior and posterior longitudinal ligaments, maintain vertebral alignment and limit hyperextension or flexion NCBIWikipedia.
-
Spacer for Neural Foramina: By maintaining intervertebral height, discs ensure adequate space for exiting spinal nerves NCBIWikipedia.
-
Protection of Vertebrae: They reduce stress concentrations on vertebral endplates, minimizing the risk of fracture or degenerative changes NCBIWikipedia.
Types of Brucellar Discitis
-
Primary Brucellar Discitis (Discitis without Spondylitis)
Characterized by isolated infection of the intervertebral disc space without contiguous vertebral involvement; exceedingly rare, with Brucella organisms directly colonizing the disc via hematogenous spread ScienceDirectMDPI. -
Brucellar Spondylodiscitis
The most common spinal manifestation of brucellosis, involving both disc and adjacent vertebral endplates; often accompanied by vertebral edema and endplate erosion on imaging ScienceDirectMDPI. -
Localized Spinal Brucellosis
Osteomyelitis restricted to the anterior discovertebral junction, causing focal endplate destruction and early disc space narrowing; may progress if untreated MDPI. -
Diffuse Spinal Brucellosis
Extensive involvement of the vertebral endplate(s) and often the entire vertebral body, leading to multilevel disease and higher risk of paravertebral or epidural abscess formation MDPILippincott Journals.
Causes (Predisposing Factors)
-
Consumption of Unpasteurized Dairy Products
Brucella spp. commonly transmit through raw milk and cheese; ingested organisms can enter the bloodstream, seeding the spine via endplate arterioles WikipediaMDPI. -
Occupational Exposure
Farmers, veterinarians, and abattoir workers handling infected livestock are at increased risk of bacteremia and subsequent disc involvement WikipediaMDPI. -
Laboratory Exposure
Accidental aerosolization in clinical or research laboratories can lead to primary brucellosis with potential spinal seeding WikipediaMDPI. -
Direct Animal Contact
Skin abrasions or mucosal exposure to infected animal fluids facilitate percutaneous entry of Brucella and hematogenous spread to the disc space WikipediaMDPI. -
Travel to Endemic Areas
Regions such as the Mediterranean basin, Middle East, and parts of Asia harbor high Brucella prevalence, heightening exposure risk during visits Wikipedia. -
Hematogenous Spread
Brucella organisms reach spinal endplates via nutrient arterioles of vertebral bodies, especially affecting lumbar segments (L5–S1 most common) MDPIMDPI. -
Contiguous Spread from Adjacent Infections
Paravertebral or psoas abscesses may extend into disc spaces, causing secondary discitis Lippincott JournalsMDPI. -
Direct Inoculation
Rare occurrences of discitis from penetrating trauma or spinal injections contaminated with Brucella-species bacteria MDPIScienceDirect. -
Advanced Age
Patients over 50 years exhibit reduced immune surveillance and increased degenerative changes, facilitating Brucella colonization of weakened discs MDPIThe Journal of Neuroscience. -
Male Gender
Higher incidence of spinal brucellosis observed in males, possibly due to occupational exposures and hormonal influences on immunity MDPIThe Journal of Neuroscience. -
Immunosuppression
Conditions or medications (e.g., steroids) impair macrophage function, increasing susceptibility to Brucella osteoarticular infection The Journal of NeuroscienceMDPI. -
Diabetes Mellitus
Hyperglycemia impairs neutrophil and macrophage activity, elevating risk for spondylodiscitis from Brucella and other pathogens PMCMedical News Today. -
HIV Infection
CD4⁺ T-cell depletion compromises granulomatous control of Brucella, allowing dissemination to bone and disc The Journal of NeuroscienceMedical News Today. -
Long-Term Systemic Steroid Use
Chronic corticosteroid therapy diminishes cellular immunity, predisposing to invasive brucellosis and disc involvement The Journal of NeuroscienceMedical News Today. -
Prior Spinal Surgery
Disruption of endplate integrity and postoperative bacteremia may seed Brucella into the disc space PMCRadiopaedia. -
Intravenous Drug Use
Repeated venous injections introduce bacteria into circulation, with potential secondary spinal seeding by Brucella or co-pathogens RadiopaediaMedical News Today. -
Urinary Tract Instrumentation
Ascending infections or instrumentation can cause transient bacteremia, occasionally seeding the spine RadiopaediaMedical News Today. -
Congestive Heart Failure
Reduced organ perfusion and venous stasis impair immune clearance, facilitating hematogenous Brucella spread to vulnerable endplates Medical News TodayScienceDirect. -
Chronic Kidney Disease
Uremia-associated immune dysfunction and regular vascular access procedures increase risk of hematogenous spinal infection Medical News TodayMaguire Online Library. -
Chronic Liver Disease
Impaired reticuloendothelial function and portal hypertension can alter bacterial clearance, raising Brucella spondylodiscitis risk Medical News TodayMaguire Online Library.
Symptoms
-
Localized Back Pain
Persistent, insidious lumbar pain is the hallmark of Brucellar discitis, often unresponsive to conventional analgesics ScienceDirectMDPI. -
Low-Grade Fever
Typically <38.5 °C, reflecting the chronic, indolent nature of brucellosis MDPIScienceDirect. -
Night Sweats
Periodic diaphoresis due to intermittent bacteremia and cytokine release ScienceDirectMDPI. -
Weight Loss
Anorexia and systemic inflammation often lead to unintentional weight reduction ScienceDirectMDPI. -
Local Tenderness
Palpation over affected segment elicits pain due to peri-endplate inflammation ScienceDirectMDPI. -
Muscle Spasm
Protective paraspinal muscle guarding around inflamed discs ScienceDirectMDPI. -
Radicular Pain
Nerve root irritation from disc space collapse or abscess formation causes shooting leg pain MDPILippincott Journals. -
Neurological Deficits
Motor weakness or sensory changes when epidural extension compresses neural elements Lippincott JournalsMDPI. -
Gait Disturbance
Due to lower limb weakness or radiculopathy Lippincott JournalsMDPI. -
Sphincter Dysfunction
Bladder or bowel incontinence from cauda equina compromise in severe cases Lippincott JournalsMDPI. -
Paravertebral Swelling
Visible swelling or palpable mass when paravertebral abscess forms Lippincott JournalsBioMed Central. -
Psoas Abscess Formation
Referred hip or thigh pain with a flexion deformity in coexisting psoas involvement Lippincott JournalsBioMed Central. -
Night Pain
Intensification of symptoms in recumbent position due to venous congestion ScienceDirectMDPI. -
Fatigue and Malaise
Systemic inflammatory response to chronic infection MDPIScienceDirect. -
Anorexia
Decreased appetite from cytokine-mediated sickness behavior MDPIScienceDirect. -
Hepatosplenomegaly
Palpable enlargement reflecting systemic dissemination of Brucella MDPIWikipedia. -
Night Chills
Cold sensations accompanying nocturnal fevers MDPIScienceDirect. -
Headache
Non-specific prodromal symptom of brucellosis MDPIScienceDirect. -
Arthralgias
Joint pain in hips or knees due to concomitant osteoarticular involvement MDPIMDPI. -
Myalgias
Muscle aches from systemic inflammatory mediators MDPIMDPI.
Diagnostic Tests
-
Magnetic Resonance Imaging (MRI)
Modality of choice; shows disc space narrowing, endplate edema (T₂ hyperintensity), and abscesses RadiopaediaRadiopaedia. -
Computed Tomography (CT)
Detects bony erosions, sequestra, and calcifications; guides CT-guided biopsy ScienceDirectMDPI. -
Plain Radiography
Late findings: disc space narrowing and endplate sclerosis; limited early sensitivity WikipediaScienceDirect. -
Blood Culture
Gold standard for brucellosis; positivity ranges 10–90%, requiring prolonged incubation (up to 4 weeks) MDPIMDPI. -
Bone Marrow Culture
Highest sensitivity (≈92%); useful when blood cultures are negative MDPIMDPI. -
Serum Agglutination Test (SAT)
Titer ≥1:160 (non-endemic) or ≥1:320 (endemic) suggests infection; fourfold rise confirms diagnosis MDPIMDPI. -
Enzyme-Linked Immunosorbent Assay (ELISA)
Quantifies specific IgM, IgG, IgA; useful in chronic or localized disease MDPIMDPI. -
Rose Bengal Test
Rapid slide agglutination for screening; high sensitivity in acute phase MDPIMDPI. -
2-Mercaptoethanol (2-ME) Test
Differentiates IgM (acute) from IgG (chronic) antibodies for disease staging MDPIMDPI. -
BrucellaCapt® (Immunocapture) Test
Measures total anti-Brucella antibodies; higher specificity in complicated cases MDPIMDPI. -
Polymerase Chain Reaction (PCR)
Rapid, high-sensitivity detection of Brucella DNA in blood or tissue (e.g., bone biopsy) MDPIMDPI. -
Bone Biopsy with Culture
CT-guided sampling of disc or vertebral body for direct pathogen isolation Lippincott JournalsMDPI. -
Giemsa Stain
Identifies intracellular Brucella in bone marrow aspirate; ancillary test MDPIMDPI. -
Complete Blood Count (CBC)
May show anemia, leukopenia or leukocytosis with relative lymphocytosis, thrombocytopenia MDPIMDPI. -
Erythrocyte Sedimentation Rate (ESR)
Typically elevated, reflecting chronic inflammation MDPIMDPI. -
C-Reactive Protein (CRP)
An acute-phase reactant that correlates with disease activity and treatment response MDPIMDPI. -
Liver Function Tests (LFTs)
Mild elevations of transaminases common in systemic brucellosis MDPIMDPI. -
Ultrasound
Detection of paravertebral or psoas abscess; guides aspiration Lippincott JournalsMDPI. -
Positron Emission Tomography (FDG-PET/CT)
Highlights metabolically active infection foci and multifocal involvement BioMed CentralMDPI. -
Antibiotic Susceptibility Testing
Guides tailored therapy by determining Brucella strain sensitivities MDPIMDPI.
Non-Pharmacological Treatments
Note: Direct evidence for many supportive measures in brucellar discitis is limited; these strategies are extrapolated from spondylodiscitis and low back pain guidelines.
-
Bed Rest
-
Description: Limiting movement during acute infection.
-
Purpose: Reduce mechanical stress, allow inflammation to settle.
-
Mechanism: Minimizes micro-motion at infected disc, aiding antibiotic penetration.
-
-
Spinal Bracing
-
Description: Use of a lumbar orthosis (brace).
-
Purpose: Immobilize spine, relieve pain.
-
Mechanism: Stabilizes vertebrae/disc, reducing load on inflamed tissue.
-
-
Gradual Mobilization
-
Description: Transition from rest to activity with brace support.
-
Purpose: Prevent muscle wasting, maintain flexibility.
-
Mechanism: Controlled loading stimulates healing without overstress.
-
-
Heat Therapy
-
Description: Application of warm packs.
-
Purpose: Relieve muscle spasm, improve circulation.
-
Mechanism: Vasodilation increases blood flow, delivering immune cells.
-
-
Cold Therapy
-
Description: Ice packs in acute pain episodes.
-
Purpose: Reduce inflammation and swelling.
-
Mechanism: Vasoconstriction limits inflammatory mediator release.
-
-
Transcutaneous Electrical Nerve Stimulation (TENS)
-
Description: Low-voltage electrical currents via skin electrodes.
-
Purpose: Pain modulation.
-
Mechanism: Gate control theory—stimulates non-nociceptive fibers to inhibit pain signals.
-
-
Therapeutic Ultrasound
-
Description: High-frequency sound waves to deep tissues.
-
Purpose: Enhance healing.
-
Mechanism: Micro-mechanical vibrations increase cell permeability and blood flow.
-
-
Electrical Muscle Stimulation
-
Description: Stimulates paraspinal muscles.
-
Purpose: Prevent atrophy.
-
Mechanism: Evokes contractions, preserving muscle tone.
-
-
Massage Therapy
-
Description: Soft tissue manipulation.
-
Purpose: Decrease muscle tension.
-
Mechanism: Mechanical pressure improves lymphatic drainage and circulation.
-
-
Acupuncture
-
Description: Needle insertion at standardized points.
-
Purpose: Analgesia.
-
Mechanism: Endorphin release, neuromodulation.
-
-
Hydrotherapy (Aquatic Therapy)
-
Description: Exercises in water.
-
Purpose: Low-impact mobilization.
-
Mechanism: Buoyancy unloads spine, resistance strengthens muscles.
-
-
Yoga & Stretching
-
Description: Gentle poses focusing on flexibility.
-
Purpose: Improve range of motion.
-
Mechanism: Soft tissue elongation, postural correction.
-
-
Pilates (Core Stabilization)
-
Description: Controlled core exercises.
-
Purpose: Strengthen supporting musculature.
-
Mechanism: Activates deep stabilizers to offload disc.
-
-
Posture Correction Education
-
Description: Training in neutral spine alignment.
-
Purpose: Minimize disc stress.
-
Mechanism: Balanced load distribution.
-
-
Ergonomic Modifications
-
Description: Adjust workspace/chair.
-
Purpose: Reduce repetitive strain.
-
Mechanism: Optimizes posture during activities.
-
-
Activity Pacing
-
Description: Alternating rest and activity.
-
Purpose: Prevent flare-ups.
-
Mechanism: Avoids cumulative stress.
-
-
Weight Management
-
Description: Achieve healthy BMI.
-
Purpose: Reduce axial load.
-
Mechanism: Less weight decreases disc pressure.
-
-
Smoking Cessation
-
Description: Stop tobacco use.
-
Purpose: Improve healing.
-
Mechanism: Enhances oxygen delivery, reduces inflammation.
-
-
Stress Management (Mindfulness, CBT)
-
Description: Techniques to manage pain-related stress.
-
Purpose: Improve coping, reduce pain perception.
-
Mechanism: Modulates central pain processing.
-
-
Assistive Devices (Lumbar Pillow)
-
Description: Supportive cushions.
-
Purpose: Maintain lordosis.
-
Mechanism: Maintains optimal disc spacing during sitting.
-
-
Orthotic Shoe Inserts
-
Description: Correct foot posture.
-
Purpose: Improve gait mechanics.
-
Mechanism: Reduces compensatory spine loading.
-
-
Kinesio Taping
-
Description: Elastic therapeutic tape on skin.
-
Purpose: Support soft tissues.
-
Mechanism: Enhances proprioception, reduces overuse.
-
-
Gait Training
-
Description: Supervised walking drills.
-
Purpose: Normalize movement patterns.
-
Mechanism: Prevents compensation, distributes load evenly.
-
-
Manual Therapy (McKenzie, Mulligan)
-
Description: Therapist-guided spinal mobilizations.
-
Purpose: Reduce stiffness.
-
Mechanism: Improves segmental mobility, reduces pain.
-
-
Spinal Decompression Therapy
-
Description: Mechanical traction on table.
-
Purpose: Decompress disc.
-
Mechanism: Negative intradiscal pressure pulls nutrients into disc.
-
-
Laser Therapy (LLLT)
-
Description: Low-level laser applied to skin.
-
Purpose: Accelerate tissue healing.
-
Mechanism: Photobiomodulation stimulates cellular repair.
-
-
Magnetic Therapy
-
Description: Static magnets applied externally.
-
Purpose: Adjunct pain relief.
-
Mechanism: Modulates nerve excitability (limited evidence).
-
-
Ergonomic Mattress
-
Description: Medium-firm support surface.
-
Purpose: Spinal alignment during sleep.
-
Mechanism: Reduces nocturnal disc pressure.
-
-
Body Mechanics Training
-
Description: Proper lifting/bending techniques.
-
Purpose: Prevent reinjury.
-
Mechanism: Engages hips/knees, not spine.
-
-
Patient Education Programs
-
Description: Structured back care workshops.
-
Purpose: Empower self-management.
-
Mechanism: Increases adherence to rehabilitation.
-
Antibiotic Drugs
Based on IDSA and brucellosis guidelines.
| Drug & Class | Dosage & Duration | Timing | Common Side Effects |
|---|---|---|---|
| 1. Doxycycline (Tetracycline) | 100 mg orally BID for ≥6 weeks | Morning & evening with water | Photosensitivity, GI upset, esophagitis |
| 2. Rifampin (Rifamycin) | 600 mg orally QD for ≥6 weeks | Morning, empty stomach | Hepatotoxicity, orange-red body fluids |
| 3. Streptomycin (Aminoglycoside) | 1 g IM QD for 14–21 days | Morning | Ototoxicity, nephrotoxicity |
| 4. Gentamicin (Aminoglycoside) | 5 mg/kg IM/IV QD for 7–10 days | Anytime | Nephrotoxicity, vestibular toxicity |
| 5. TMP–SMX (Sulfonamide) | 160/800 mg orally BID for >6 weeks | Morning & evening | Rash, bone marrow suppression, hyperkalemia |
| 6. Ciprofloxacin (Fluoroquinolone) | 500 mg orally BID for ≥8 weeks | Morning & evening | Tendinopathy, QT prolongation |
| 7. Levofloxacin (Fluoroquinolone) | 500–750 mg orally QD for ≥6 weeks | Morning | Insomnia, dizziness, tendon rupture |
| 8. Chloramphenicol (Amphenicol) | 500 mg orally QID for 4 weeks | Every 6 h | Aplastic anemia, gray baby syndrome |
| 9. Minocycline (Tetracycline) | 100 mg orally BID for ≥6 weeks | Morning & evening | Dizziness, skin pigmentation |
| 10. Azithromycin (Macrolide) | 500 mg orally QD for 3 weeks | Evening | GI upset, QT prolongation |
| 11. Moxifloxacin (Fluoroquinolone) | 400 mg orally QD for ≥6 weeks | Morning | Hepatotoxicity, myopathy |
| 12. TMP–SMX + Doxycycline | As above, combination | As above | Combined risk of GI, photosensitivity |
| 13. Doxycycline + Streptomycin | 100 mg BID + 1 g IM QD for 6 weeks | Morning & shot after dose | Combined GI & ototoxic risks |
| 14. Doxycycline + Gentamicin | 100 mg BID + 5 mg/kg IM QD for 7 days | Morning & shot after dose | Combined GI & nephrotoxic risks |
| 15. Doxycycline + TMP–SMX | 100 mg BID + 160/800 mg BID for 6 weeks | Morning & evening | Combined bone marrow & photosensitivity |
| 16. Rifampin + TMP–SMX | 600 mg QD + 160/800 mg BID for 6 weeks | Morning & evening | Combined hepatotoxicity & marrow suppression |
| 17. Doxycycline + Rifampin + Streptomycin | As above + 1 g IM QD for first 2 weeks | Morning & shot after dose | Multi-drug toxicity |
| 18. Ceftriaxone (Cephalosporin) | 2 g IV QD for ≥6 weeks | Anytime | Biliary sludging, gallstones |
| 19. Ampicillin–Sulbactam (Penicillin) | 3 g IV TID for ≥6 weeks | Every 8 h | Allergic reactions, GI upset |
| 20. Amoxicillin–Clavulanate (Penicillin) | 875/125 mg orally BID for 6 weeks | Morning & evening | Diarrhea, liver enzyme elevation |
Dietary Molecular Supplements
All doses refer to adults; adjust for body weight and comorbidities.
-
Curcumin
-
Dosage: 500–1,500 mg daily (standardized extract).
-
Function: Anti-inflammatory, antioxidant.
-
Mechanism: Inhibits NF-κB, COX-2, downregulates TNF-α, IL-1β.
-
-
Omega-3 Fatty Acids (EPA/DHA)
-
Dosage: 2–4 g combined EPA+DHA daily.
-
Function: Reduces inflammation.
-
Mechanism: Competes with arachidonic acid, decreases pro-inflammatory eicosanoids (IL-1, TNF-α).
-
-
Vitamin D
-
Dosage: 800–2,000 IU daily.
-
Function: Immune modulation, bone health.
-
Mechanism: Upregulates antimicrobial peptides (cathelicidin), downregulates inflammatory cytokines.
-
-
Vitamin C
-
Dosage: 500–1,000 mg daily.
-
Function: Antioxidant, collagen synthesis.
-
Mechanism: Scavenges free radicals, cofactor for prolyl hydroxylase in collagen formation.
-
-
Probiotics (e.g., Lactobacillus spp.)
-
Dosage: ≥10 billion CFU daily.
-
Function: Immune support.
-
Mechanism: Modulates gut microbiota, enhances IgA production, competes with pathogens.
-
-
Zinc
-
Dosage: 8–15 mg daily (≤40 mg).
-
Function: Immune regulation, anti-inflammatory.
-
Mechanism: Cofactor for T/B cell function, inhibits NF-κB signaling.
-
-
Magnesium
-
Dosage: 300–400 mg daily.
-
Function: Muscle relaxation, nerve function.
-
Mechanism: Natural calcium antagonist, NMDA receptor modulation, reduces cytokine release.
-
-
Collagen Peptides
-
Dosage: 2.5–15 g daily.
-
Function: Supports disc matrix.
-
Mechanism: Provides glycine/proline for extracellular matrix synthesis, stimulates fibroblast activity.
-
-
Glucosamine Sulfate
-
Dosage: 1,500 mg daily.
-
Function: Cartilage precursor.
-
Mechanism: Substrate for glycosaminoglycan synthesis, may modulate chondrocyte activity.
-
-
Chondroitin Sulfate
-
Dosage: 1,200 mg daily.
-
Function: Cartilage cushion.
-
Mechanism: Attracts water into cartilage, inhibits degradative enzymes, anti-inflammatory.
-
Advanced “Drug” Therapies
(Bisphosphonates, Regenerative, Viscosupplement, Stem Cell)
-
Alendronate (Bisphosphonate)
-
Dosage: 70 mg orally once weekly.
-
Function: Inhibits osteoclasts.
-
Mechanism: Binds hydroxyapatite, blocks farnesyl pyrophosphate synthase, induces osteoclast apoptosis.
-
-
Risedronate (Bisphosphonate)
-
Dosage: 35 mg orally once weekly.
-
Function: Reduces bone resorption.
-
Mechanism: Similar to alendronate; high affinity for bone mineral.
-
-
Zoledronic Acid (Bisphosphonate)
-
Dosage: 5 mg IV infusion over ≥15 min once yearly.
-
Function: Potent anti-resorptive.
-
Mechanism: Inhibits osteoclast function and survival via mevalonate pathway blockade.
-
-
Platelet-Rich Plasma (PRP) (Regenerative)
-
Dosage: 3–5 mL autologous PRP injected intradiscally.
-
Function: Tissue repair.
-
Mechanism: Releases growth factors (PDGF, TGF-β), stimulates nucleus pulposus cell proliferation.
-
-
Recombinant BMP-2 (Regenerative)
-
Dosage: 1.4–12 mg per spinal fusion level (on collagen sponge).
-
Function: Osteoinduction.
-
Mechanism: Promotes mesenchymal stem cell differentiation into osteoblasts, bone formation.
-
-
Hyaluronic Acid (Viscosupplement)
-
Dosage: 1–2 mL of 1.5% solution injected into disc/facet joint.
-
Function: Lubrication, anti-inflammatory.
-
Mechanism: Restores viscoelasticity, binds CD44 to inhibit cytokine signaling (IL-1β, TNF-α).
-
-
Autologous MSC Injection (Stem Cell)
-
Dosage: 1–5 million cells/disc.
-
Function: Regenerate disc tissue.
-
Mechanism: Differentiate into nucleus pulposus-like cells, secrete ECM and trophic factors.
-
-
Allogeneic Mesenchymal Precursor Cells (Stem Cell)
-
Dosage: 6 million or 18 million cells in HA carrier.
-
Function: Anti-inflammatory, regenerative.
-
Mechanism: Immunomodulation, secrete growth factors, support disc cell survival.
-
-
BMP-7 (OP-1) (Regenerative)
-
Dosage: Human use under HDE, variable.
-
Function: Alternative to autograft.
-
Mechanism: Osteoinductive, enhances fusion rates.
-
-
Platelet-Rich Fibrin (PRF) (Regenerative)
-
Dosage: 1–3 mL autologous PRF gel.
-
Function: Sustained growth factor release.
-
Mechanism: Scaffold plus PDGF/TGF-β to promote matrix synthesis.
-
Surgical Procedures
Indications: neurologic deficit, instability, epidural abscess >2.5 cm, deformity.
-
Anterior Debridement & Fusion
-
Posterior Laminectomy & Debridement
-
Transpedicular Debridement & Drainage
-
Anterior Stand-alone Decompression & Reconstruction
-
Posterior Instrumentation & Fusion
-
Anterior-Posterior Combined Approach
-
Corpectomy with Cage Reconstruction
-
Minimally Invasive Endoscopic Debridement
-
Percutaneous CT-guided Abscess Aspiration
-
Vertebral Body Resection & Pelvic Fixation
Prevention Strategies
Focus on brucellosis control to prevent disc infection. World Health OrganizationMayo Clinic
-
Pasteurization of Dairy Products
-
Vaccination of Livestock (Rev-1, RB51)
-
Test-and-Slaughter Programs
-
Animal Infection Surveillance
-
Occupational PPE (Gloves, Masks) in Farms/Slaughterhouses
-
Boil Meat & Dairy before Consumption
-
Public Education on Brucellosis Risks
-
Laboratory Biosafety Protocols
-
Hand Hygiene after Animal Handling
-
Avoid Raw Milk/Cheese while Traveling
Red Flags: When to See a Doctor
-
Persistent severe back pain >6 weeks
-
Fever, night sweats, weight loss
-
Neurological signs (weakness, numbness)
-
Radicular pain unresponsive to analgesics
-
Elevated CRP/ESR despite antibiotics
FAQs
-
What is brucellar discitis?
Brucellar discitis is a rare infection of the spine’s cushioning discs caused by Brucella bacteria. It leads to back pain, fever, and sometimes nerve symptoms. -
How do people get infected?
By drinking raw milk/cheese or direct contact with infected animals (sheep, goats, cattle). Mayo Clinic -
What are the main symptoms?
Chronic low back pain, low-grade fever, night sweats, and occasional nerve pain down the legs. -
How is it diagnosed?
MRI shows disc changes; blood tests show raised inflammatory markers; brucella serology (agglutination test) and culture/PCR confirm diagnosis. -
Why is combination antibiotic therapy used?
Brucella hides inside cells; two drugs ensure bacteria are killed in both acidic and neutral compartments. -
How long is treatment?
Typically 6–12 weeks of two or more antibiotics to prevent relapse. -
Can non-drug measures help?
Yes—rest, bracing, physiotherapy, heat/cold, and nutrition support healing and reduce pain. -
Are dietary supplements necessary?
Supplements like vitamin D, curcumin, omega-3s support immune health but cannot replace antibiotics. -
Is surgery always needed?
No—only if there’s nerve compression, spinal instability, large abscess, or failure of medical therapy. -
What are the risks of surgery?
Bleeding, infection, nerve injury, hardware failure; benefits must outweigh risks. -
How can I prevent recurrence?
Complete antibiotic course, follow-up MRI/labs, avoid risk factors (raw dairy). -
Can I exercise?
Light, guided rehab after acute phase aids recovery; avoid heavy lifting until cleared. -
When will I feel better?
Pain often improves in 2–4 weeks of treatment; labs normalize in 4–8 weeks. -
Is it contagious to others?
Human-to-human transmission is extremely rare; main risk is from animals/raw dairy. Wikipedia -
What’s the long-term outlook?
With prompt treatment, most recover fully; delayed care can cause chronic pain or deformity.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team Rxharun and reviewed by the Rx Editorial Board Members
Last Updated: May 10, 2025.